CHOP researchers will receive funds to discover a new drug that targets MYCN, a transcription factor involved in some pediatric cancers.

Large study provides head impact sensor analysis across four sports and both genders, a first for basketball and field hockey.

The findings identify possible targets for future therapies for ribosomopathies, childhood disorders that lead to bone marrow failure (BMF).

CHOP researchers have identified RNA editing events that influence gene expression and phenotype, showing that a single nucleotide change can have large downstream effects.

CHOP expert leading the effort to develop a chatbot to screen children for suicide risk in a more efficient and scalable manner.

Using deep immune profiling, CHOP researchers have found children with MIS-C are extremely immune activated, more like adults with severe COVID-19.

A study involving CHOP researchers has found the two strategies used for treating infants with symptomatic tetralogy of Fallot both have potential benefits for patients.

CHOP researchers have found mice exposed to neonatal hyperoxia have increased influenza susceptibility and disrupted lung circadian clocks.

Study is first to demonstrate how one specific combinational therapy may provide measurable benefits to patients with mitochondrial respiratory chain disorders, which currently lack FDA-approved therapies.

CHOP researchers describe different types of rashes they have seen in patients diagnosed with the COVID-19-related inflammatory syndrome.